denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Scientific Program
Session: JOINT Session - The Lymphoma Microenvironment and Its Impact on Therapy
Hematology Disease Topics & Pathways:
Biological therapies, Antibody Therapy, Clinical Practice (Health Services and Quality), Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, Combination therapy, genomics, Diversity, Equity, and Inclusion (DEI) , T Cell lymphoma, Diseases, indolent lymphoma, immune mechanism, aggressive lymphoma, Therapies, Lymphoid Malignancies, metabolism, Biological Processes, pathogenesis
Session: JOINT Session - The Lymphoma Microenvironment and Its Impact on Therapy
Hematology Disease Topics & Pathways:
Biological therapies, Antibody Therapy, Clinical Practice (Health Services and Quality), Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, Combination therapy, genomics, Diversity, Equity, and Inclusion (DEI) , T Cell lymphoma, Diseases, indolent lymphoma, immune mechanism, aggressive lymphoma, Therapies, Lymphoid Malignancies, metabolism, Biological Processes, pathogenesis
Sunday, December 11, 2022, 9:30 AM-11:05 AM
Disclosures: No relevant conflicts of interest to declare.
See more of: JOINT Session - The Lymphoma Microenvironment and Its Impact on Therapy
See more of: Scientific Program
See more of: Scientific Program